Juul heads to Japan
After a series of setbacks, US based vape company Juul Labs Inc is looking to penetrate the Japan market.
Reported by Bloomberg, it has set up Juul Labs Japan Co under the leadership of Haruhiko Hirate formerly of Tokyo-based Takeda Pharmaceutical Co, the company must acquire a license to sell their nicotine-containing pods which are classified as a pharmaceutical product which is still pending.
In his statement, Hirate said Juul “must be a responsible and science-driven company that earns the trust with public health stakeholders an society”.
“I look forward to ensuring that Juul Labs Japan Co. Ltd. takes such a methodical approach as it explores bringing its electronic nicotine delivery system to Japan’s 19 million smokers,” he said.
The company has faced multiple setbacks in its expansion plans such as being removed from online stores in China, a ban in India and even struggling to gain a footing in South Korea, under its rapid global expansion plan.